Invasive fungal infection Hematologic malignancy Invasive fungal infection Hematologic malignancy Chemotherapy Indoor fungal concentration Hemato-Oncology ward
Conditions
Interventions
Participants that stay in the room with mean fungal spore concentration from 100 CFU/m3 and higher during admission period.,Participants that stay in the room with mean fungal spore concentration lowe
Other,Other
High fungal burden group,Low fungal burden group
Sponsors
Routine to research fund, Siriraj Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged 18 years old and older 2. Has been diagnosed with hematologic malignancy and receiving chemotherapy
Exclusion criteria
Exclusion criteria: 1. Active invasive fungal infection with concurrent treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between fungal colony count and invasive fungal infection in hematological malignancy patients receiving chemotherapy At admission date and 1 month post-discharged History taking and clinical data from electronic medical record | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors for invasive fungal infection among hematological malignancy patients receiving chemotherapy At admission date and 1 month post-discharged History taking and clinical data from electronic medical record,Incidence of invasive fungal infection At admission date and 1 month post-discharged History taking and clinical data from electronic medical record,The amount of fungal colony count in hematology ward Time during admission Fungal concentration amount | — |
Countries
Thailand
Contacts
Public ContactMethee Chayakulkeeree
Faculty of Medicine Siriraj Hospital
Outcome results
None listed